Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Technology Stocks Rip Higher In Buying Frenzy, What's Next?

Published 07/21/2020, 03:04 AM
Updated 09/20/2023, 06:34 AM

Stocks rose yesterday, in what was one the strangest rallies I have seen in some time. The market had a sense of panic to it, just as much in the way stocks fall. It could be there was some short-covering to yesterday’s rally because it was only the technology names that rallied.

It seems that the QQQs will want to continue to climb, and I would think, at the very least, they will want to retest the highs from last week around $270. Perhaps, some of this is merely reshuffling from the options expirations as dealers needed to reposition themselves.

After a while, this game becomes incredibly confusing and frustrating, because mostly I try to form my opinion on what I see in both options and technical trends, for this daily trading stuff. My longer fundamental views are in a sperate basket. Last week all of the trends and options betting were pointing lower. Then days like yesterday come along, and it is incredibly frustrating.

QQQ Chart

NVIDIA

NVIDIA (NASDAQ:NVDA) was up yesterday, but the stock is in the same position it was in last week, and so, therefore, nothing changes in my book. I still think the stock is heading lower.

NVIDIA Corp 1 Hr Chart

GE

General Electric (NYSE:GE) didn’t have a great day, but again there was bullish betting in this one with size. It would suggest that prices eventually go higher, but it may take until after earnings for them to happen.

General Electric Daily Chart

Amazon

Amazon (NASDAQ:AMZN) was up nearly 8%. So that you realize that is over $100 billion in market cap. That is bigger than many companies in the S&P 500. That is a tremendous move. The stock stalled at resistance at 3,200. I don’t think this mania lasts, and we reverse lower. I still think to 2,800.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Amazon Inc Chart

Acadia

I am very saddened that ACADIA Pharmaceuticals's (NASDAQ:ACAD) pimavanserin didn’t prove efficacy in depression. It was very disappointing. I am happy to hear that the FDA did accept the companies sNDA for pimavanserin in Dementia-related psychosis; the big positive is that the FDA is not planning an ADCOM. It was primarily expected there would be an ADCOM, so the fact that it will not be is positive. The stock is trading down after hours, to around $49. The stock has reliable support at $48.

Acadia Pharma Inc Chart

Original Post

Latest comments

this is a big casino, place your bets please 🎈🎈
In my view, no body can predict stock market, in fact Warren buffet, this tym failed to calculate. I sometimes feel, this is not at all valuation game, more like a gambling with the support of News
Many have proposed barbell portfolio strategies, the value/Russell reopening trade vs the work/shop/eat/entertain at home (tech/online shopping) trade. As the money center banks indicated last week, reopening the economy will take much longer than the market is pricing in, even at these depressed levels. Thus bloated tech valuations will befuddle us, sellside analysts will continue raising price targets... BUT techs will continue to soar cuz these companies are innovating, profitable, still growing and, in general, flush with cash or have the ability to raise equity at high prices.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.